Fludarabine Phosphate bulk supplier for pharma manufacturers

Fludarabine Phosphate Suppliers & Bulk Manufacturers

Available Forms: Injection (IV), Oral Tablet

Available Strengths: Injection: 25 mg/ml; Tablet: 10 mg

Reference Brands: Fludara® (US & EU)

Fludarabine Phosphate is an oncology drug used to treat CLL and blood cancers. Available as a 25 mg/mL IV injection and 10 mg tablets in the US and EU.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Fludarabine Phosphate is a widely used oncology medication indicated for chronic lymphocytic leukemia (CLL) and certain non-Hodgkin’s lymphomas. It is available in the US and EU as a 25 mg/mL injection and 10 mg oral tablets. Marketed under the brand name Fludara® and as generics, Fludarabine Phosphate is a purine analog that interferes with DNA synthesis, promoting apoptosis in malignant cells. It is a critical chemotherapy option in hematologic cancer protocols and widely used in hospital oncology units and pharma B2B distribution. Its established efficacy and regulatory approval make it a trusted choice across global markets.

Fludarabine Phosphate — third party manufacturing & bulk supply

Fludarabine Phosphate is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Fludarabine Phosphate is supplied as Injection (IV), Oral Tablet — supplied in more than one dosage form, each with its own manufacturing economics, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Fludarabine Phosphate listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Fludarabine Phosphate →

Back to Listing

Frequently Asked Questions

Fludarabine Phosphate is listed as Injection (IV), Oral Tablet in Injection: 25 mg/ml; Tablet: 10 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Fludarabine Phosphate is referenced against Fludara® (US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.